Trium Capital LLP Invests $7.54 Million in AstraZeneca PLC (NASDAQ:AZN)
MarketBeat
Trium Capital LLP acquired a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 102,641 shares of the company's stock, valued at approximately $7,544,000. AstraZeneca makes up approximat
NASDAQ:AZN